- Published at
- by manilatimes.net
positive
positive
News for Verrica Pharmaceuticals Inc. (VRCA)
- Published at
- by gurufocus.com
mixedmixedVerrica Pharmaceuticals Appoints Gavin Corcoran, M.D. to its Board of Directors
WEST CHESTER, Pa., April 02, 2025 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (”Verrica” or the ”Company”) ( VRCA), a dermatology therapeutics co- Published at
- by manilatimes.net
mixedmixed- Published at
- by manilatimes.net
mixedmixed- Published at
- by gurufocus.com
mixedmixedVerrica Pharmaceuticals to Report Fourth Quarter and Full Year 2024 Financial Results and Provide a Corporate Update on March 11, 2025
WEST CHESTER, Pa., March 03, 2025 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (”Verrica” or ”the Company”) ( VRCA), a dermatology therapeutics co- Published at
- by gurufocus.com
positivepositiveVerrica Pharmaceuticals to Participate in the TD Cowen 45th Annual Health Care Conference in Boston
WEST CHESTER, Pa., Feb. 25, 2025 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (”Verrica” or ”the Company”) ( VRCA), a dermatology therapeutics com- Published at
- by gurufocus.com
positivepositiveARMISTICE CAPITAL, LLC Acquires Significant Stake in Verrica Pharmaceuticals Inc
On December 31, 2024, ARMISTICE CAPITAL, LLC (Trades, Portfolio) executed a noteworthy transaction by acquiring 9,134,817 shares of Verrica Pharmaceuticals Inc- Published at
- by gurufocus.com
positivepositivePERCEPTIVE ADVISORS LLC Reduces Stake in Verrica Pharmaceuticals Inc
On December 31, 2024, PERCEPTIVE ADVISORS LLC (Trades, Portfolio) executed a notable transaction involving Verrica Pharmaceuticals Inc (VRCA). The firm reduced- Published at
- by gurufocus.com
positivepositiveCaligan Partners LP Acquires Significant Stake in Verrica Pharmaceuticals Inc
On December 31, 2024, Caligan Partners LP (Trades, Portfolio) made a strategic move by acquiring 15,856,653 shares of Verrica Pharmaceuticals Inc. This transact- Published at
- by benzinga.com
mixedmixedVerrica Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - Verrica Pharmaceuticals (NASDAQ:VRCA)
WEST CHESTER, Pa., Dec. 09, 2024 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (- Published at
- by manilatimes.net
mixedmixed- Published at
- by seekingalpha.com
positivepositiveVerrica Pharmaceuticals stock dips after pricing $42M securities offering (NASDAQ:VRCA)
Verrica Pharmaceuticals announces a $42M securities offering for common stock and warrants, with shares down 10% in premarket trading.- Published at
- by manilatimes.net
positivepositive- Published at
- by gurufocus.com
mixedmixedVerrica Announces Proposed Public Offering
WEST CHESTER, Pa., Nov. 20, 2024 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (”Verrica” or the ”Company”) ( VRCA), a dermatology therapeutics com- Published at
- by manilatimes.net
mixedmixed- Published at
- by gurufocus.com
neutralneutralVerrica Pharmaceuticals Reports Q3 2024 EPS of -$0.49 and Revenue of -$1.9 Million, Misses Estimates
Revenue: Reported negative net product revenue of $1.9 million, significantly below the estimated revenue of $4.63 million, due to a provision for product retu- Published at
- by investing.com
mixedmixedU.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.88% By Investing.com
U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.88%- Published at
- by benzinga.com
positivepositiveDow Jumps 400 Points; Yum! Brands Posts Downbeat Earnings - Yum Brands (NYSE:YUM)
U.S. stocks traded higher toward the end of trading, with the S&P 500 gaining around 1% on Tuesday. The Dow traded up 0.96% to 42,197.88 while the NASDAQ rose ...- Published at
- by benzinga.com
positivepositive- Published at
- by investing.com
positivepositiveUroGen Pharma retains stock target, buy rating with new CFO By Investing.com
UroGen Pharma retains stock target, buy rating with new CFO